Skip to main content
Allie Graham on Muck Rack

Allie Graham

Toronto
As seen in: Nature, PLOS ONE, The Decibel, BioRxiv, Cell Press, Texas Medical Center, CANADALAND, The Coast, The Dalhousie Gazette
🔊producer, editor, bitch, lover 🎢 @iheartmedia poog & how to citizen s4 📻 w/ @transmitterpods, @crookedmedia, @globeandmail, @cbcpodcasts, @IMPSTR | she/her
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Allie

Contact Allie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Skinny, Inc. Part 3: Body image in the age of Ozempic

|
By Sherrill Sutherland Verified, Kasia Mychajlowycz Verified, Allie Graham
| The Decibel Verified
Open this photo in gallery: Pens for the diabetes drug Ozempic sit on a production line at the Danish drugmaker Novo Nordisk's site in Hillerod, Denmark in 2023. The first episode of Skinny Inc. was all about the science behind GLP-1s, and the second episode was about the business, from the pharmaceutical companies who make GLP-1s to the insurance plans that may or may not cover it. Today, we’re exploring how the so-called “Ozempic era,” affects people’s mental health.
Open in Who Shared Issue with article?

Convergent Reduction of Olfactory Genes and Olfactory Bulb Size in Mammalian Species at Altitude

|
By Allie Graham
| Texas Medical Center
Publication Date 7-7-2025 DOI 10.1016/j.cub.2025.05.061 PubMedCentral® Posted Date 12-12-2025 PubMedCentral® Full Text Version Author MSS Abstract The invasion of specialized ecological niches can cause drastic changes to selection regimes, resulting in genomic and phenotypic transformation.
Open in Who Shared Issue with article?

Skinny, Inc. Part 2: The big business of Ozempic

|
By Kasia Mychajlowycz Verified, Allie Graham
| The Decibel Verified
Open this photo in gallery: Ozempic pens sit on a production line to be packaged at the Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, in 2023. You can listen to the first episode of this three-part series here. GLP-1 medications to treat diabetes, obesity and several other illnesses have exploded in popularity since Ozempic was approved for use in Canada back in 2018.
Open in Who Shared Issue with article?
See all 61 articles